Simulations Plus Inc. (SLP)
NASDAQ: SLP
· Real-Time Price · USD
17.03
-0.30 (-1.73%)
At close: Jun 23, 2025, 3:59 PM
17.54
2.99%
After-hours: Jun 23, 2025, 07:45 PM EDT
-1.73% (1D)
| Bid | 17.15 |
| Market Cap | 342.49M |
| Revenue (ttm) | 78.56M |
| Net Income (ttm) | 7.22M |
| EPS (ttm) | 0.36 |
| PE Ratio (ttm) | 47.31 |
| Forward PE | 14.79 |
| Analyst | Buy |
| Ask | 17.55 |
| Volume | 306,981 |
| Avg. Volume (20D) | 400,329 |
| Open | 17.25 |
| Previous Close | 17.33 |
| Day's Range | 16.88 - 17.49 |
| 52-Week Range | 16.84 - 49.71 |
| Beta | 0.97 |
Analyst Forecast
According to 0 analyst ratings, the average rating for SLP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Simulations Plus Inc. is scheduled to release its earnings on Jul 14, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+26.85%
Shares of healthcare technology stocks are trading...
Unlock content with
Pro Subscription
2 months ago
+0.74%
Simulations Plus shares are trading higher. The stock may be moving up after the FDA stated plans to phase out animal testing requirements for monoclonal antibodies and other drugs.
